Chief Financial Officer · Immunome Inc. · Immunome Inc. — Stock Option (right to buy)
Side
M
Value
—
Shares
60.0K
Price
—
Executed
Jun 15, 2026
Disclosed
Jun 17, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 15 executedJun 17, 2026 disclosed
IMNM · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rosett Max filed this Form 4 reporting a option exercise of IMNM on Jun 15, 2026. It became public on Jun 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Rosett Maxcik:0001994071
Issuer
Immunome Inc.cik:0001472012
Revision history · 0
No field has changed since this record was first ingested.
